Market Closed -
Other stock markets
|
After market 06:01:22 pm | |||
311.4 USD | -1.45% | 310.8 | -0.20% |
Apr. 25 | UBS Cuts Humana's Price Target to $326 From $334, Maintains Neutral Rating | MT |
Apr. 25 | Jefferies Adjusts Price Target on Humana to $365 From $381 | MT |
Evolution of the average Target Price on Humana Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Humana Inc.
TD Cowen | |
Jefferies & Co. | |
Mizuho Securities | |
Zacks Investment Research | |
Truist Securities | |
Wells Fargo Securities | |
Goldman Sachs | |
UBS | |
Raymond James | |
Argus | |
Nephron Research | |
Stephens Inc. | |
Cantor Fitzgerald | |
Deutsche Bank Securities | |
Oppenheimer | |
RBC Capital Markets | |
JPMorgan Chase | |
Bernstein | |
Morgan Stanley | |
SVB Securities LLC | |
Cowen | |
Credit Suisse | |
Loop Capital | |
BMO Capital | |
Barclays | |
SVB Leerink | |
Citigroup | |
Seaport Global Securities |
EPS Revisions
- Stock Market
- Equities
- HUM Stock
- Consensus Humana Inc.